PREMUROSA
PERMUROSA
Abstract
Musculoskeletal diseases are a major burden on individuals, healthcare and welfare systems, and their treatment is currently based either on prosthetic or regenerative surgical procedures, often involving medical device implantation. The EU-funded PREMUROSA project aims to train a new generation of scientists with an integrated vision of the whole value chain in musculoskeletal regeneration technologies. The project will boost an environment of innovations that develop devices and optimised clinical applications using interdisciplinary, intersectoral and international approaches. The new generation of researchers will sharpen their experimental and complementary skills in a well-designed and diversified training programme.
Consortium
Universita Degli Studi Del Piemonte Orientale Amedeo Avogadro (Coordinator), Aalto Korkeakoulusaatio SR, Istituto Ortopedico Rizzoli, AO-Forschungsinstitut Davos, Rigas Tehniska Universitate, Faculty Of Technology And Metallurgy University of Belgrade, INEB-Instituto Nacional De Engenharia Biomedica, Politecnico di Torino, Enginsoft SPA, Tampereen Korkeakoulusaatio SR, National University of Ireland Galway
For more information visit: PREMUROSA
NEUcrest
Abstract
Neural crest cells are a transient group of embryonic cells that migrate extensively, giving rise not only to most of the peripheral nervous system but also to cells of the adrenal gland, smooth muscle cells of the cardiovascular system, pigment cells in the skin, and craniofacial bones, cartilage, and connective tissue. Neurocristopathies (NCP) result from abnormalities in neural crest cells, and cancers such as melanoma and neuroblastoma are linked to them. However, it is difficult to trace pathologies to specific mutations in these cells. NEUcrest is harnessing the power of early stage researchers to tease out the complex aspects of neural cell and tumour formation, and more generally, the regulation of neural cell tissue in human health
Consortium
Institut Curie (Coordinator) King's College London, University of East Anglia, NUI Galway, Universidad Miguel Hernandez De Elche, Erasmus Universitair Medisch Centrum Rotterdam, Medizinische Universitaet Wien, Tel Aviv University, Stemcell Technologies UK LTD, Azelead, Imagine Institut des Maladies Genetiques Necker Enfants Malades Fondation
For more information visit: NEUcrest [https://science.institut-curie.org/research/biology-chemistry-of-radiations-cell-signaling-and-cancer-axis/umr-3347-normal-and-pathological-signaling/team-monsoro-burq/european-neucrest-itn-network/]